Olazabal-Herrero Anne, García-Santisteban Iraia, Rodríguez Jose Antonio
Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, Leioa, 48940, Spain.
Mol Cancer. 2015 Feb 6;14(1):33. doi: 10.1186/s12943-015-0311-7.
In complex with its cofactor UAF1, the USP1 deubiquitinase plays an important role in cellular processes related to cancer, including the response to DNA damage. The USP1/UAF1 complex is emerging as a novel target in cancer therapy, but several aspects of its function and regulation remain to be further clarified. These include the role of the serine 313 phosphorylation site, the relative contribution of different USP1 sequence motifs to UAF1 binding, and the potential effect of cancer-associated mutations on USP1 regulation by autocleavage.
We have generated a large set of USP1 structural variants, including a catalytically inactive form (C90S), non-phosphorylatable (S313A) and phosphomimetic (S313D) mutants, deletion mutants lacking potential UAF1 binding sites, a mutant (GG/AA) unable to undergo autocleavage at the well-characterized G670/G671 diglycine motif, and four USP1 mutants identified in tumor samples that cluster around this cleavage site (G667A, L669P, K673T and A676T). Using cell-based assays, we have determined the ability of these mutants to bind UAF1, to reverse DNA damage-induced monoubiquitination of PCNA, and to undergo autocleavage.
A non-phosphorylatable S313A mutant of USP1 retained the ability to bind UAF1 and to reverse PCNA ubiquitination in cell-based assays. Regardless of the presence of a phosphomimetic S313D mutation, deletion of USP1 fragment 420-520 disrupted UAF1 binding, as determined using a nuclear relocation assay. The UAF1 binding site in a second UAF1-interacting DUB, USP46, was mapped to a region homologous to USP1(420-520). Regarding USP1 autocleavage, co-expression of the C90S and GG/AA mutants did not result in cleavage, while the cancer-associated mutation L669P was found to reduce cleavage efficiency.
USP1 phosphorylation at S313 is not critical for PCNA deubiquitination, neither for binding to UAF1 in a cellular environment. In this context, USP1 amino acid motif 420-520 is necessary and sufficient for UAF1 binding. This motif, and a homologous amino acid segment that mediates USP46 binding to UAF1, map to the Fingers sub-domain of these DUBs. On the other hand, our results support the view that USP1 autocleavage may occur in cis, and can be altered by a cancer-associated mutation.
泛素特异性蛋白酶1(USP1)去泛素化酶与其辅因子UAF1结合时,在与癌症相关的细胞过程中发挥重要作用,包括对DNA损伤的反应。USP1/UAF1复合物正在成为癌症治疗中的一个新靶点,但其功能和调控的几个方面仍有待进一步阐明。这些方面包括丝氨酸313磷酸化位点的作用、不同USP1序列基序对UAF1结合的相对贡献,以及癌症相关突变对USP1自切割调控的潜在影响。
我们构建了大量USP1结构变体,包括催化无活性形式(C90S)、不可磷酸化(S313A)和模拟磷酸化(S313D)突变体、缺乏潜在UAF1结合位点的缺失突变体、在特征明确的G670/G671双甘氨酸基序处无法进行自切割的突变体(GG/AA),以及在肿瘤样本中鉴定出的围绕该切割位点聚集的四个USP1突变体(G667A、L669P、K673T和A676T)。使用基于细胞的检测方法,我们确定了这些突变体结合UAF1、逆转DNA损伤诱导的PCNA单泛素化以及进行自切割的能力。
在基于细胞的检测中,USP1的不可磷酸化S313A突变体保留了结合UAF1和逆转PCNA泛素化的能力。无论是否存在模拟磷酸化的S313D突变,使用核转位检测法确定,USP1片段420 - 520的缺失都会破坏UAF1结合。另一种与UAF1相互作用的去泛素化酶USP46中,UAF1结合位点被定位到与USP1(420 - 520)同源的区域。关于USP1自切割,C90S和GG/AA突变体的共表达未导致切割,而发现癌症相关突变L669P会降低切割效率。
S313位点的USP1磷酸化对于PCNA去泛素化以及在细胞环境中与UAF1结合均不关键。在这种情况下,USP1氨基酸基序420 - 520对于UAF1结合是必要且充分的。该基序以及介导USP46与UAF1结合的同源氨基酸片段,定位于这些去泛素化酶的指状亚结构域。另一方面,我们的结果支持USP1自切割可能以顺式发生且可被癌症相关突变改变的观点。